Log in
Forgot password ?
Become a member for free
Sign up
Sign up
Dynamic quotes 

4-Traders Homepage  >  Equities  >  CANADIAN NATIONAL STOCK EXCHANGE  >  Beleave Inc    BE   CA0775611084

Mes dernières consult.
Most popular
News SummaryMost relevantAll newsofficial PublicationsSector newsTweets
OFFRE ETE Zonebourse : Jusqu'à 6 mois offerts sur tous les portefeuilles
The feature you requested does not exist. However, we suggest the following feature:

Beleave : Applauds Canadian Leadership and Continued Progress of Cannabis Legalization

share with twitter share with LinkedIn share with facebook
share via e-mail
06/22/2018 | 02:13pm CEST

TORONTO, June 22, 2018 /CNW/ - Beleave Inc. (CSE: BE) (OTCQX: BLEVF) ("Beleave" or the "Company") would like to commend the outstanding leadership, tenacity, and bravery of the Canadian government in passing Bill C-45 into law. As the first G7 country to legalize cannabis, this forever reaffirms Canada's reputation as a forward-thinking nation to live and do business in.

Beleave Inc. (CNW Group/Beleave Inc.)

Beleave continues to build its distribution to be well-positioned to meet the demand of the recreational and medical cannabis markets.  The Company's greenhouse expansion in Hamilton is well underway while it is continuing to expand its network of medical clinics by way of the Medi-Green brand and its recreational retail stores through a newly-granted retail license in Saskatchewan.  The Saskatchewan license is the first of many proposed retail locations the Company plans to roll out in Canada which will offer a diverse range of products available both online and in store.

"Beleave has had a great year so far," said Beleave's CEO, Andrew Wnek. "This milestone has been a long-time coming and now that it's here we can celebrate another win and move forward. We feel the comprehensive regulatory framework for adult cannabis use is fair and will work to eliminate the black market, protect our youth, and remain mindful of public health and safety."

The Company released news yesterday announcing its global expansion into Colombia, a jurisdiction believed to be right behind Canada on the path to legalized and regulated cannabis. The Company plans to strike more deals in a well thought out and strategic manner advantageous to shareholder growth without paying the high premiums currently associated with todays cannabis marketplace.

"We've raised roughly $20 million in the last several months, strengthening the company's balance sheet to capitalize on industry opportunities. We thank our investors for their continued confidence and support," commented Bojan Krasic, Beleave's Director and CFO. "Also, we acknowledge the diligence of our amazing team. Their hard work, dedication, and innovation has prepared us like never before for this next chapter in Beleave's story."

About Beleave

Beleave is a biotech company and the Company's wholly-owned subsidiary Beleave Kannabis Corp. is licensed to cultivate and sell medical cannabis and produce cannabis oils and extracts pursuant to Health Canada's Access to Cannabis for Medical Purpose Relations. Beleave has been selected to operate in Saskatchewan's upcoming cannabis retail market and has developed a network of medical cannabis clinics under the Medi-Green banner. The Company has applied for various patents to broaden its strong research focused foundation.

Forward-Looking Statements

This news release contains "forward-looking information" within the meaning of applicable securities law ("forward-looking statements"). The use of any of the words "plan", "anticipate", "continue", "estimate", "expect", "may", "will", "project", "should", "believe" and other similar words, or statements that certain events or conditions "may" or "will" occur are intended to identify forward-looking information. These statements are only predictions. Although the Company believes that the expectations and assumptions on which the forward-looking information is based are reasonable, undue reliance should not be placed on the forward-looking information because the Company can give no assurance that they will prove to be correct. Since forward-looking information addresses future events and conditions, by its very nature it involves inherent risks and uncertainties. This information speak only as of the date of this news release. Actual results could differ materially from those currently anticipated due to a number of factors and risks including various risk factors discussed in the Company's disclosure documents, which can be found under the Company's profile on www.sedar.com.

Cision View original content with multimedia:http://www.prnewswire.com/news-releases/beleave-applauds-canadian-leadership-and-continued-progress-of-cannabis-legalization-300670725.html

SOURCE Beleave Inc.

© Canada Newswire, source Canada Newswire English

share with twitter share with LinkedIn share with facebook
share via e-mail
Latest news on BELEAVE INC
06/22BELEAVE : Applauds Canadian Leadership and Continued Progress of Cannabis Legali..
06/21BELEAVE : Expands its Global Footprint into Colombia
06/11BELEAVE INC : . Announces Closing of First Tranche of Non-Brokered Private Place..
06/09BELEAVE INC : . Announces $5 Million Non-Brokered Private Placement of Units
06/05BELEAVE INC : . Announces Successful Selection to Operate a Cannabis Retail Stor..
06/04BELEAVE INC : . Announces Successful Selection to Operate a Cannabis Retail Stor..
05/22BELEAVE : Expands Medi-Green Cannabis Clinic Network with Additional Location in..
05/17BELEAVE : R E P E A T — Beleave Provides Guidance on Veterans Affairs Cana..
05/17BELEAVE : R E P E A T -- Beleave Provides Guidance on Veterans Affairs Canada Co..
05/16BELEAVE : Provides Guidance on Veterans Affairs Canada Coverage
More news
News from SeekingAlpha
05/29WEEKLY CANNABIS REPORT : $2.1 Billion Shorts, Hydropothecary, Invictus 
05/23COMPLETE CANNABIS GUIDE #4 : Provincial Regulations In Canada 
05/21WEEKLY CANNABIS REPORT : Arb Trade, Hiku, Cronos, Namaste 
05/15WEEKLY CANNABIS REPORT : Aurora/MedReleaf, Canopy, Maricann 
05/08WEEKLY CANNABIS REPORT : MedReleaf Sell, TGOD IPO, Loblaw Wins 
Financials ( CAD)
Sales 2018 -
EBIT 2018 -4,80 M
Net income 2018 -8,10 M
Debt 2018 -
Yield 2018 -
P/E ratio 2018 -
P/E ratio 2019
Capi. / Sales 2018 0
Capi. / Sales 2019 0
Capitalization 78,7 M
Duration : Period :
Beleave Inc Technical Analysis Chart | BE | CA0775611084 | 4-Traders
Income Statement Evolution
Mean consensus BUY
Number of Analysts 1
Average target price 2,00  CAD
Spread / Average Target 27%
EPS Revisions
Andrew T. Wnek Chief Executive Officer
Roger Ferreira President, Chief Science Officer & Director
Vasilios Panagiotakopoulos Chief Operational Officer & Director
Bojan Krasic Chief Financial Officer & Director
Christopher Robin Murphy Director & Head-Distribution & Operations
Sector and Competitors
1st jan.Capitalization (M$)
BELEAVE INC-38.35%59
GENMAB-3.97%9 722